Results of HLA class II typing in 2019
| Trial | Specimen | Resolution | HLA-DR | No. of labs | HLA-DQ | No. of labs |
|---|---|---|---|---|---|---|
| 1st | IHL-19-01 | Generic type | DRB1*11/DRB1*14 | 65 | DQB1*03/DQB1*05 | 36 |
| Allelic type | DRB1*11:01/DRB1*14:05 | 21 | DQB1*03:01/DQB1*05:03 | 8 | ||
| DRB1*11:01G/DRB1*14:05 | 1 | |||||
| DRB1*11:01G/DRB1*14:05G | 3 | |||||
| Serological equivalent | DR11/DR14 | 64 | DQ7/DQ5 | 36 | ||
| IHL-19-02 | Generic type | DRB1*04/DRB1*05 | 1 | DQB1*02/DQB1*04 | 36 | |
| DRB1*04/DRB1*07 | 64 | |||||
| Allelic type | DRB1*04:05/DRB1*07:01 | 22 | DQB1*02:02/DQB1*04:01 | 12 | ||
| DRB1*04:05G/DRB1*07:01G | 3 | DQB1*02:02G/DQB1*04:01G | 1 | |||
| Serological equivalent | DR4/DR5 | 1 | DQ2/DQ4 | 36 | ||
| DR4/DR7 | 63 | |||||
| 2nd | IHL-19-03 | Generic type | DRB1*13/DRB1*15 | 65 | DQB1*03/DQB1*06 | 41 |
| Allelic type | DRB1*13:01/DRB1*15:02 | 1 | DQB1*03:01/DQB1*06:04 | 14 | ||
| DRB1*13:02/DRB1*15:01 | 20 | DQB1*03:01G/DQB1*06:04G | 1 | |||
| DRB1*13:02/DRB1*15:01G | 1 | |||||
| DRB1*13:02G/DRB1*15:01G | 4 | |||||
| Serological equivalent | DR13/DR15 | 65 | DQ6/DQ7 | 44 | ||
| IHL-19-04 | Generic type | DRB1*07/DRB1*11 | 65 | DQB1*02/DQB1*03 | 41 | |
| Allelic type | DRB1*07:01/DRB1*11:01 | 21 | DQB1*02:02/DQB1*03:02 | 14 | ||
| DRB1*07:01G/DRB1*11:01 | 1 | DQB1*02:02G/DQB1*03:02G | 1 | |||
| DRB1*07:01G/DRB1*11:01G | 4 | |||||
| Serological equivalent | DR7/DR11 | 65 | DQ2/DQ8 | 42 |
Bold letter indicates the results which are not compliant with the intended responses.
Abbreviation: HLA, human leukocyte antigen.